Provided by Tiger Trade Technology Pte. Ltd.

Dianthus Therapeutics Inc.

103.28
-3.7600-3.51%
Post-market: 103.280.00000.00%19:58 EDT
Volume:535.82K
Turnover:56.17M
Market Cap:5.78B
PE:-25.11
High:107.64
Open:105.88
Low:101.60
Close:107.04
52wk High:117.88
52wk Low:32.22
Shares:55.93M
Float Shares:55.85M
Volume Ratio:0.83
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1130
EPS(LYR):-4.2037
ROE:-26.07%
ROA:-17.69%
PB:4.93
PE(LYR):-24.57

Loading ...

Dianthus Therapeutics Inc : Citigroup Initiates Coverage with Buy Rating; Target Price $156

THOMSON REUTERS
·
Sep 04

Dianthus EVP, Head of R&D Simrat Randhawa Sells USD 2.45 Million in Common Shares

Reuters
·
Sep 04

Dianthus Therapeutics Grants 52,000 Inducement Stock Options at $106.62 Each

Reuters
·
Sep 03

Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 03

Dianthus Therapeutics CEO to Join Citi Biopharma Back to School Fireside Chat

Reuters
·
Sep 01

Dianthus Therapeutics Director Simon Read Disposes of Common Shares Worth $326,148.9

Reuters
·
Aug 20

U.S. Research Roundup- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies

Reuters
·
Aug 17

Dianthus Therapeutics (DNTH) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Aug 13

Dianthus Therapeutics SVP General Counsel Adam Veness Melepas Saham Senilai USD 2,21 Juta

Reuters
·
Aug 12

Analysts’ Top Healthcare Picks: Dianthus Therapeutics (DNTH), Elanco Animal Health (ELAN)

TIPRANKS
·
Aug 11

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Dianthus Therapeutics (DNTH)

TIPRANKS
·
Aug 10

Dianthus Therapeutics CEO Marino Garcia Reports Disposal of 166,000 Common Shares Worth $17.97 Million

Reuters
·
Aug 08

Viridian Therapeutics Q2 Net Loss Widens as Lumvoa Launch Lifts Costs

Reuters
·
Aug 06

Climb Bio Q2 Net Loss Widens on Pipeline Advancement

Reuters
·
Aug 06

Dianthus Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $158 from $130

THOMSON REUTERS
·
Aug 06

U.S. Research Roundup-Caterpillar, Eli Lilly, McKesson

Reuters
·
Aug 06

Dianthus Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Arcus Biosciences Q2 Revenue Falls Sharply on Lower License Income

Reuters
·
Aug 06

Enliven Therapeutics Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 06

Black Diamond Therapeutics Q2 Net Loss Narrows Year over Year

Reuters
·
Aug 06